Ramesh K. Gupta

Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

Richard Furie, Eric F. Morand, Ian N Bruce et al. · The Lancet Rheumatology · 2019 · 442 citations · Full text

Inflammation, Autoimmune Disease, Systemic Lupus Erythematosus Treatment +10

Prospective evaluation of safety and efficacy of the supracostal approach for percutaneous nephrolithotomy

Ramesh K. Gupta, Ashok Kumar, Rakesh Kapoor et al. · British Journal of Urology · 2002 · 145 citations

Mianserin Hydrochloride: A Novel Antidepressant

Alec Coppen, Ramesh K. Gupta, Stuart Montgomery et al. · The British Journal of Psychiatry · 1976 · 108 citations

Medicinal Chemistry, Psychoactive Drug, Pharmacological Study +13

A Double-Blind Comparison of Lithium Carbonate and Maprotiline in the Prophylaxis of the Affective Disorders

Alec Coppen, S.A. Montgomery, Ramesh K. Gupta et al. · The British Journal of Psychiatry · 1976 · 106 citations

Benign Brain Tumours and Psychiatric Morbidity: A 5-Years Retrospective Data Analysis

Ramesh K. Gupta, Rajeev Kumar · Australian & New Zealand Journal of Psychiatry · 2004 · 83 citations

Case Records, Neuropsychiatry, Brain Lesion +23